Jci_page_head_homepage_01 Jci_page_head_homepage_02
Franco R. D’Alessio, Kenji Tsushima, Neil R. Aggarwal, Erin E. West, Matthew H. Willett, Martin F. Britos, Matthew R. Pipeling, Roy G. Brower, Rubin M. Tuder, John F. McDyer, Landon S. King
Published in Volume 119, Issue 10
J Clin Invest. 2009; 119(10):2898–2913 doi:10.1172/JCI36498
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 9
Alveolar Tregs are present in humans with ALI.

Mini-BAL and blood sampling was performed on days 0, 1, and 2 relative to enrollment. (A) Patient 1 BAL flow cytometry panels for CD3+, CD4+ and CD8+, and CD3+CD4+CD25hiCD127loFoxp3+ cells, as well as flow cytometry for CD3+CD4+CD25hiCD127loFoxp3+ cells in the blood compartment. Intracellular staining with human isotype control Ab for FoxP3, in cells gated as described above, is also shown. Numbers within plots denote the percentage of cells in the respective quadrants or gated regions. (B) Absolute number of CD3+CD4+CD25hiCD127loFoxp3+ Tregs in the BAL (right axis) and blood (left axis) over time in patients with ALI. (C) Absolute number of CD3+CD4+CD25hiCD127loFoxp3+ Tregs in the blood of patients with ALI.